Therapy

Sarepta Therapeutics

$97.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.04%) Today
+$1.04 (+1.07%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SRPT and other stocks, options, and ETFs commission-free!

About SRPT

Sarepta Therapeutics, Inc. Common Stock (DE), also called Sarepta Therapeutics, is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA. The listed name for SRPT is Sarepta Therapeutics, Inc. Common Stock (DE).

CEO
Douglas S. Ingram
Employees
743
Headquarters
Cambridge, Massachusetts
Founded
1980
Market Cap
7.64B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.69M
High Today
$103.31
Low Today
$96.40
Open Price
$99.59
Volume
2.92M
52 Week High
$181.83
52 Week Low
$78.06

Collections

SRPT Earnings

-$1.86
-$1.24
-$0.62
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 24, After Hours

You May Also Like

KBSF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure